Report Detail

Medical Devices & Consumables Global Off-body Wearable Injectors Market Research Report 2021

  • RnM4299921
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Off-body Wearable Injectors Market Overview

  • 1.1 Product Overview and Scope of Off-body Wearable Injectors
  • 1.2 Off-body Wearable Injectors Segment by Type
    • 1.2.1 Global Off-body Wearable Injectors Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Electronical Injectors
    • 1.2.3 Mechanical Injectors
    • 1.2.4 Others
  • 1.3 Off-body Wearable Injectors Segment by Application
    • 1.3.1 Off-body Wearable Injectors Sales Comparison by Application: (2021-2027)
    • 1.3.2 Immuno-oncology
    • 1.3.3 Diabetes
    • 1.3.4 Cardiovascular Diseases
    • 1.3.5 Other
  • 1.4 Global Off-body Wearable Injectors Market Size Estimates and Forecasts
    • 1.4.1 Global Off-body Wearable Injectors Revenue 2016-2027
    • 1.4.2 Global Off-body Wearable Injectors Sales 2016-2027
    • 1.4.3 Off-body Wearable Injectors Market Size by Region: 2016 Versus 2021 Versus 2027

2 Off-body Wearable Injectors Market Competition by Manufacturers

  • 2.1 Global Off-body Wearable Injectors Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Off-body Wearable Injectors Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Off-body Wearable Injectors Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Off-body Wearable Injectors Manufacturing Sites, Area Served, Product Type
  • 2.5 Off-body Wearable Injectors Market Competitive Situation and Trends
    • 2.5.1 Off-body Wearable Injectors Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Off-body Wearable Injectors Players Market Share by Revenue
    • 2.5.3 Global Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Off-body Wearable Injectors Retrospective Market Scenario by Region

  • 3.1 Global Off-body Wearable Injectors Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Off-body Wearable Injectors Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Off-body Wearable Injectors Market Facts & Figures by Country
    • 3.3.1 North America Off-body Wearable Injectors Sales by Country
    • 3.3.2 North America Off-body Wearable Injectors Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Off-body Wearable Injectors Market Facts & Figures by Country
    • 3.4.1 Europe Off-body Wearable Injectors Sales by Country
    • 3.4.2 Europe Off-body Wearable Injectors Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Off-body Wearable Injectors Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Off-body Wearable Injectors Sales by Region
    • 3.5.2 Asia Pacific Off-body Wearable Injectors Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Off-body Wearable Injectors Market Facts & Figures by Country
    • 3.6.1 Latin America Off-body Wearable Injectors Sales by Country
    • 3.6.2 Latin America Off-body Wearable Injectors Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Off-body Wearable Injectors Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Off-body Wearable Injectors Sales by Country
    • 3.7.2 Middle East and Africa Off-body Wearable Injectors Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Off-body Wearable Injectors Historic Market Analysis by Type

  • 4.1 Global Off-body Wearable Injectors Sales Market Share by Type (2016-2021)
  • 4.2 Global Off-body Wearable Injectors Revenue Market Share by Type (2016-2021)
  • 4.3 Global Off-body Wearable Injectors Price by Type (2016-2021)

5 Global Off-body Wearable Injectors Historic Market Analysis by Application

  • 5.1 Global Off-body Wearable Injectors Sales Market Share by Application (2016-2021)
  • 5.2 Global Off-body Wearable Injectors Revenue Market Share by Application (2016-2021)
  • 5.3 Global Off-body Wearable Injectors Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Becton, Dickinson and Company
    • 6.1.1 Becton, Dickinson and Company Corporation Information
    • 6.1.2 Becton, Dickinson and Company Description and Business Overview
    • 6.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Becton, Dickinson and Company Product Portfolio
    • 6.1.5 Becton, Dickinson and Company Recent Developments/Updates
  • 6.2 Medtronic
    • 6.2.1 Medtronic Corporation Information
    • 6.2.2 Medtronic Description and Business Overview
    • 6.2.3 Medtronic Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Medtronic Product Portfolio
    • 6.2.5 Medtronic Recent Developments/Updates
  • 6.3 Johnson & Johnson
    • 6.3.1 Johnson & Johnson Corporation Information
    • 6.3.2 Johnson & Johnson Description and Business Overview
    • 6.3.3 Johnson & Johnson Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Johnson & Johnson Product Portfolio
    • 6.3.5 Johnson & Johnson Recent Developments/Updates
  • 6.4 Insulet Corporation
    • 6.4.1 Insulet Corporation Corporation Information
    • 6.4.2 Insulet Corporation Description and Business Overview
    • 6.4.3 Insulet Corporation Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Insulet Corporation Product Portfolio
    • 6.4.5 Insulet Corporation Recent Developments/Updates
  • 6.5 Unilife Corporation
    • 6.5.1 Unilife Corporation Corporation Information
    • 6.5.2 Unilife Corporation Description and Business Overview
    • 6.5.3 Unilife Corporation Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Unilife Corporation Product Portfolio
    • 6.5.5 Unilife Corporation Recent Developments/Updates
  • 6.6 Enable Injections
    • 6.6.1 Enable Injections Corporation Information
    • 6.6.2 Enable Injections Description and Business Overview
    • 6.6.3 Enable Injections Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Enable Injections Product Portfolio
    • 6.6.5 Enable Injections Recent Developments/Updates
  • 6.7 SteadyMed
    • 6.6.1 SteadyMed Corporation Information
    • 6.6.2 SteadyMed Description and Business Overview
    • 6.6.3 SteadyMed Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 SteadyMed Product Portfolio
    • 6.7.5 SteadyMed Recent Developments/Updates
  • 6.8 Ypsomed Group
    • 6.8.1 Ypsomed Group Corporation Information
    • 6.8.2 Ypsomed Group Description and Business Overview
    • 6.8.3 Ypsomed Group Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Ypsomed Group Product Portfolio
    • 6.8.5 Ypsomed Group Recent Developments/Updates
  • 6.9 West Pharmaceutical Services
    • 6.9.1 West Pharmaceutical Services Corporation Information
    • 6.9.2 West Pharmaceutical Services Description and Business Overview
    • 6.9.3 West Pharmaceutical Services Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 West Pharmaceutical Services Product Portfolio
    • 6.9.5 West Pharmaceutical Services Recent Developments/Updates
  • 6.10 Unilife
    • 6.10.1 Unilife Corporation Information
    • 6.10.2 Unilife Description and Business Overview
    • 6.10.3 Unilife Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Unilife Product Portfolio
    • 6.10.5 Unilife Recent Developments/Updates
  • 6.11 CeQur
    • 6.11.1 CeQur Corporation Information
    • 6.11.2 CeQur Off-body Wearable Injectors Description and Business Overview
    • 6.11.3 CeQur Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 CeQur Product Portfolio
    • 6.11.5 CeQur Recent Developments/Updates
  • 6.12 Sensile Medical
    • 6.12.1 Sensile Medical Corporation Information
    • 6.12.2 Sensile Medical Off-body Wearable Injectors Description and Business Overview
    • 6.12.3 Sensile Medical Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Sensile Medical Product Portfolio
    • 6.12.5 Sensile Medical Recent Developments/Updates
  • 6.13 Roche
    • 6.13.1 Roche Corporation Information
    • 6.13.2 Roche Off-body Wearable Injectors Description and Business Overview
    • 6.13.3 Roche Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Roche Product Portfolio
    • 6.13.5 Roche Recent Developments/Updates
  • 6.14 ScPharmaceuticals
    • 6.14.1 ScPharmaceuticals Corporation Information
    • 6.14.2 ScPharmaceuticals Off-body Wearable Injectors Description and Business Overview
    • 6.14.3 ScPharmaceuticals Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 ScPharmaceuticals Product Portfolio
    • 6.14.5 ScPharmaceuticals Recent Developments/Updates
  • 6.15 SteadyMed
    • 6.15.1 SteadyMed Corporation Information
    • 6.15.2 SteadyMed Off-body Wearable Injectors Description and Business Overview
    • 6.15.3 SteadyMed Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 SteadyMed Product Portfolio
    • 6.15.5 SteadyMed Recent Developments/Updates

7 Off-body Wearable Injectors Manufacturing Cost Analysis

  • 7.1 Off-body Wearable Injectors Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Off-body Wearable Injectors
  • 7.4 Off-body Wearable Injectors Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Off-body Wearable Injectors Distributors List
  • 8.3 Off-body Wearable Injectors Customers

9 Off-body Wearable Injectors Market Dynamics

  • 9.1 Off-body Wearable Injectors Industry Trends
  • 9.2 Off-body Wearable Injectors Growth Drivers
  • 9.3 Off-body Wearable Injectors Market Challenges
  • 9.4 Off-body Wearable Injectors Market Restraints

10 Global Market Forecast

  • 10.1 Off-body Wearable Injectors Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Off-body Wearable Injectors by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Off-body Wearable Injectors by Type (2022-2027)
  • 10.2 Off-body Wearable Injectors Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Off-body Wearable Injectors by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Off-body Wearable Injectors by Application (2022-2027)
  • 10.3 Off-body Wearable Injectors Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Off-body Wearable Injectors by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Off-body Wearable Injectors by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Electronical Injectors
    Mechanical Injectors
    Others

    Segment by Application
    Immuno-oncology
    Diabetes
    Cardiovascular Diseases
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Becton, Dickinson and Company
    Medtronic
    Johnson & Johnson
    Insulet Corporation
    Unilife Corporation
    Enable Injections
    SteadyMed
    Ypsomed Group
    West Pharmaceutical Services
    Unilife
    CeQur
    Sensile Medical
    Roche
    ScPharmaceuticals
    SteadyMed


    Summary:
    Get latest Market Research Reports on Off-body Wearable Injectors. Industry analysis & Market Report on Off-body Wearable Injectors is a syndicated market report, published as Global Off-body Wearable Injectors Market Research Report 2021. It is complete Research Study and Industry Analysis of Off-body Wearable Injectors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,108.83
    3,163.25
    4,217.67
    2,432.67
    3,649.00
    4,865.33
    317,445.60
    476,168.40
    634,891.20
    217,376.75
    326,065.13
    434,753.50
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report